Heparin Market in the U.S. to Hit USD 1 Bn by 2026: Global Market Insights, Inc.
Major U.S. heparin market players include Pfizer, Amphastar Pharmaceutical, Sanofi, Shenzhen Hepalink, Fresenius Kabi and Nanjing King-Friend Biochemical Pharmaceutical.
Selbyville, Delaware, Dec. 01, 2020 (GLOBE NEWSWIRE) --
According to latest report “U.S. Heparin Market by Product (Low Molecular Weight Heparin, Unfractionated Heparin), Application (Venous Thromboembolism, Atrial Fibrillation/Flutter, Coronary Artery Disease), Distribution Channel (Hospital Pharmacy, Retail Pharmacy, Online Pharmacy), Regional Outlook, Price Trends, Competitive Market Share & Forecast 2026”, by Global Market Insights, Inc., the market valuation of heparin in the United States will cross $1 billion by 2026.
High demand for anticoagulant drugs for coronary artery disease as well as venous thromboembolism is a major impact rendering factor responsible for the market growth. As per the Society of Thoracic Surgeons database, the isolated cases of coronary artery bypass grafting (CABG) is approximately 200,000 cases annually in U.S. Similarly, the overall number of cardiac surgeries that involved either CABG procedures or valve replacement and repair procedures increased by more than 6.5% between the same timeframe. With constant rise in number of such procedures, the demand for heparin will only witness an upward trend in the future. However, high risk of side effects associated with heparin may hamper the market expansion.
Request for a sample of this research report @ https://www.gminsights.com/request-sample/detail/4868
The low molecular weight heparin segment in the U.S. heparin market accounted for USD 535.4 million in 2019 owing to increasing usage of low molecular weight heparin in the treatment of coagulation disorders as well as surgical procedures. Growing number of cases that are being affected with deep vein thrombosis (DVT) will subsequently increase demand for low molecular weight heparin. Furthermore, rising demand in various healthcare settings due to growing burden of cardiovascular and chronic diseases will drive the market value.
The coronary artery disease segment revenue was over USD 148.5 million in 2019. Increasing prevalence of coronary artery disease will spur the market demand in the future. For instance, according to the Center for Disease Control and Prevention report, coronary heart disease (CAD) is the most common type of heart disease in U.S., accounting for 365,914 individual deaths in 2017. The report also stated that about 18.2 million adults aged 20 years and above have CAD. Such high pervasiveness of disease condition will increase the heparin treatment demand.
The online pharmacy distribution channel held more than 13.4% of the U.S. heparin market share in 2019. The online pharmacies offer benefits such as discounts, wide range of product availability, doorstep delivery and easy mobilization. Such benefits will attract large population or consumers and fuel the segment growth. Additionally, rising popularity of online shopping among young population will further foster the segment expansion.
A few notable companies operating in the U.S. heparin market include Pfizer, Amphastar Pharmaceutical, Sanofi, Shenzhen Hepalink, Fresenius Kabi and Nanjing King-Friend Biochemical Pharmaceutical among others. Industry players are focusing on various strategies such as acquisition, business expansion and novel product launches to consolidate their market presence.
Request for customization of this research report @
https://www.gminsights.com/roc/4868
Some major findings of the U.S. heparin market report include:
The demand for anti-coagulant drugs is on the rise across the U.S. for the treatment of coagulation disorders will boost the value of heparin market in the U.S. region.
Low molecular weight heparin (LMWH) is widely used in various healthcare settings driven by growing burden of chronic diseases that will further augment the industry growth.
Online pharmacies offer benefits such as doorstep delivery and wide range of product preference that will attract large population and consumers.
Table of Contents (ToC) of the report:
Chapter 3 U.S. Heparin Market Insights
3.1 Industry segmentation
3.2 Industry landscape, 2015 - 2026
3.3 Industry impact forces
3.3.1 Growth drivers
3.3.2 Industry pitfalls & challenges
3.4 Growth potential analysis
3.4.1 By product
3.4.2 By application
3.4.3 By distribution channel
3.5 COVID-19 impact analysis
3.6 Porter’s analysis
3.7 Competitive landscape, 2019
3.8 PESTEL analysis
Browse Complete Table of Contents (ToC) @
https://www.gminsights.com/toc/detail/us-heparin-market
About Global Market Insights, Inc.
Global Market Insights, Inc., headquartered in Delaware, U.S., is a global market research and consulting service provider, offering syndicated and custom research reports along with growth consulting services. Our business intelligence and industry research reports offer clients with penetrative insights and actionable market data specially designed and presented to aid strategic decision making. These exhaustive reports are designed via a proprietary research methodology and are available for key industries such as chemicals, advanced materials, technology, renewable energy, and biotechnology.
CONTACT: Contact Us: Arun Hegde Corporate Sales, USA Global Market Insights, Inc. Phone: 1-302-846-7766 Toll Free: 1-888-689-0688 Email: sales@gminsights.com
